Latest News

27-02-2015 Half Year Statement
24-02-2015 Europe Patent Phenotypic Screening
17-02-2015 Shareholder Update February 2015
02-02-2015 Appendix 4C - Quarterly Report
19-01-2015 Phylogica Presentation at 2015 Biotech Showcase San Francisco
News archive

Subscribe to our newsletter

Receive our latest news and announcements instantly


Phylogica is a leading peptide drug discovery company that utilises proprietary Phylomer peptide libraries and screening methodologies to identify unique peptide drug candidates for its pharmaceutical and biotechnology partners.

Phylomer® libraries contain the world's largest and most structurally diverse array of natural peptides. These peptides, known as Phylome® peptides, are sourced from evolutionary diverse microbes and they represent a new class of biological therapeutics. Phylomer® peptides display exceptional structural stability, specificity and affinity thereby giving them the potential to address disease targets that are intractable to small molecules and other protein biologics including antibodies. Read more



© 2015 Phylogica    |    ABN 48 098 391 961    |    Privacy Statement
Last updated: 12-03-2015    |    Website by Harmonic New Media and College Hill Life Sciences